Delivery Order SPE2DB20D3101-SPE2DB24FRKB5

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a prescription medication, with a ceiling value of $27,559.39. The contract is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,240.83 and covers the supply of Advair HFA 45-21 MCG inhalers. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.58 fixed-price delivery order is for the supply of Advair HFA 45-21 MCG Inhaler, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,877.94, is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $45,444.47, is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,835.97 fixed-price delivery order is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of June 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The contract is a Delivery Order with a Firm Fixed Price pricing type, a Ceiling Value of $3,467.28, and an Ultimate Completion Date of March 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, with a total ceiling value of $4,869.38. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 1, 2024. This award is not associated with any set-aside requirements. Amerisourcebergen holds a larger...
This federal contract award, valued at $4,571.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg inhalers, a pharmaceutical product used in the treatment of respiratory conditions. The contract has a completion date of June 21, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRKB5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The contract is for the delivery of an Advair HFA 45-21 mcg inhaler product, with a ceiling value of $14,492.10 and a completion date of May 13, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award is associated with that larger IDC contract. The contract does not have a set-aside designation.

Generated 8/9/24, 9:44 AM